Background & aims Sarcopenia is a risk factor for adverse outcomes in older adults, but this
has yet to be confirmed in chronic kidney disease (CKD). We conducted a systematic review …

Chronic kidney disease–mineral and bone disorder (CKD–MBD) is a systemic disorder that
affects multiple organs and systems and increases the risk of morbidity and mortality in …

Rationale & Objective Frailty is common in individuals with chronic kidney disease (CKD)
and increases the risk of adverse outcomes in adults with kidney failure requiring dialysis …

Objectives Frailty is commonly observed in patients with chronic kidney disease (CKD) and
is associated with adverse outcomes. Protein-energy wasting (PEW), a state of decreased …

Sarcopenia and frailty are prevalent in the chronic kidney disease (CKD) population.
Sarcopenia is characterised by the loss of muscle mass and function, while frailty is defined …

Background There is wide heterogeneity in physical function tests available for clinical and
research use, hindering our ability to synthesize evidence. The aim of this review was to …

Background Frailty is associated with adverse outcomes in patients undergoing
hemodialysis (HD). However, no study has used various frailty assessments in patients on …

Results Of 386 individuals, 162 progressed to dialysis. Both assessments were completed
by 98% of individuals for the Physical Activity Scale for the Elderly, 86% for the chair stand …

Objective The Short Physical Performance Battery (SPPB) is recommended for evaluating
physical performance in patients on hemodialysis (HD). However, the association between …

Background Frailty is common in chronic kidney disease (CKD) patients and becomes more
prevalent as kidney disease progresses. This study aimed to investigate the prevalence of …